MedPath

Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy

Not Applicable
Completed
Conditions
Pain
Catheter Complications
Interventions
Procedure: transurethral catheter after EERPE/ RALP
Procedure: suprapubic catheter after EERPE /RALP
Registration Number
NCT01465594
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

The study aims to show the technical feasibility of the suprapubic urinary diversion after endoscopic extraperitoneal radical prostatectomy (EERPE) and has a greater comfort for the patients with at least the same catheter complication rate in comparison to the urethral urinary diversion.

Detailed Description

Patients are randomized 1:1 in the different arms Recording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
106
Inclusion Criteria
  • Adenocarcinoma of the prostate,
  • Subjects treated by conventional or robotic assisted laparoscopic prostatectomy
  • Be willing/able to adhere to follow up visits
Exclusion Criteria
  • Subjects treated by retropubic or perineal prostatectomy Subjects with known bladder cancer
  • Contraindications for anticholinergic drugs
  • Waist measurement > 100 cm
  • No written informed consent
  • Age < 18 years
  • Subjects with known narrow-angle glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transurethral catheter after EERPE/ RALPtransurethral catheter after EERPE/ RALPRecording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics
suprapubic catheter after EERPE /RALPsuprapubic catheter after EERPE /RALPRecording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics
suprapubic catheter after EERPE /RALPtransurethral catheter after EERPE/ RALPRecording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics
transurethral catheter after EERPE/ RALPsuprapubic catheter after EERPE /RALPRecording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics
Primary Outcome Measures
NameTimeMethod
Superiority of suprapubic catheter after EERPE2nd postoperative day

Superiority of suprapubic catheter versus transurethral catheter regarding QoL /Patient comfort

Secondary Outcome Measures
NameTimeMethod
Comparison of QoL in both arms measured by visual analogue (pain) scale1st and 3rd until 5th postoperative day

Comparison of QoL in both arms measured by visual analogue (pain) scale, EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics.

Trial Locations

Locations (1)

University Hospital, Urological department

🇩🇪

Düsseldorf, Germany

© Copyright 2025. All Rights Reserved by MedPath